SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001929354-23-000002
Filing Date
2023-04-11
Accepted
2023-04-11 16:51:36
Documents
1
Period of Report
2023-04-10

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 6244
  Complete submission text file 0001929354-23-000002.txt   7963
Mailing Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850
Business Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850 410-522-8707
Avalo Therapeutics, Inc. (Issuer) CIK: 0001534120 (see all company filings)

IRS No.: 450705648 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address PALM GROVE HOUSE WICKHAMS CAY 1 ROAD TOWN TORTOLA D8 VG1110
Business Address PALM GROVE HOUSE WICKHAMS CAY 1 ROAD TOWN TORTOLA D8 VG1110 00377 99 90 25 95
Caissa Capital Management ltd. (Reporting) CIK: 0001929354 (see all company filings)

State of Incorp.: D8 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37590 | Film No.: 23813867